Cart 2
  • Anti-Ephrin-A1/EFNA1 antibody
  • Anti-Ephrin-A1/EFNA1 antibody

Anti-Ephrin-A1/EFNA1 antibody

Cat.#: 102251

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-Ephrin-A1/EFNA1 antibody
  • Documents
  • Description
    Rabbit polyclonal to Ephrin-A1/EFNA1
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Human EphrinA1 / EFNA1
  • Alternative names
    B61 antibody; EFL1 antibody; ECKLG antibody; EPLG1 antibody; LERK1 antibody; LERK-1 antibody; TNFAIP4 antibody; B61 antibody; Efl1 antibody; Epl1 antibody; Eplg1 antibody; Lerk1 antibody; AI325262 antibody; AI325262 antibody; B61 antibody; B61 antibody; ECKLG antibody; Efl1 antibody; EFL1 antibody; Efna1 antibody; EFNA1 antibody; Ephrin A1 antibody; Ephrin-A1 antibody; Epl1 antibody; Eplg1 antibody; EPLG1 antibody; Lerk1 antibody; LERK1 antibody; TNFAIP4 antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Human EphrinA1 / EFNA1 (rh EphrinA1; NP_004419.2; Met 1-Ser182). EphrinA1 specific IgG was purified by human EphrinA1 affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS with 5% trehalose
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA: 0.5-1.0 μg/mL

    This antibody can be used at 0.5-1.0 μg/mL with the appropriate secondary reagents to detect Human EFNA1. The detection limit for Human EFNA1 is 0.00245 ng/well.

    IHC-P: 0.1-2 μg/mL

  • Validations

    Ephrin-A1 / EFNA1 Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    Ephrin-A1 / EFNA1 Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    Immunochemical staining of human EFNA1 in human breast carcinoma with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to epithelium. The left panel: tissue incubated with primary antibody; The right panel: tissue incubated with the mixture of primary antibody and antigen (recombinant protein).

    Ephrin-A1 / EFNA1 Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    Ephrin-A1 / EFNA1 Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    Immunochemical staining of human EFNA1 in human gallbladder with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to epithelium. The left panel: tissue incubated with primary antibody; The right panel: tissue incubated with the mixture of primary antibody and antigen (recombinant protein).

  • Background
    EPH-related receptor tyrosine kinase ligand 1 (abbreviated as Ephrin-A1) also known as ligand of eph-related kinase 1 or EFNA1, is a member of the ephrin (EPH) family. The Eph family receptor interacting proteins (ephrins) are a family of proteins that serve as the ligands of the Eph receptor, which compose the largest known subfamily of receptor protein-tyrosine kinases (RTKs). Ephrin-A1/EFNA1 and its Eph family of receptor tyrosine kinases are expressed by cells of the SVZ. Ephrin subclasses are further distinguished by their mode of attachment to the plasma membrane: ephrin-A ligands bind EphA receptors and are anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) linkage, whereas ephrin-B ligands bind EphB receptors and are anchored via a transmembrane domain. An exception is the EphA4 receptor, which binds both subclasses of ephrins. Ephrin-A1 and one of its receptor EphA2 were expressed in xenograft endothelial cells and also tumor cells and play a role in human cancers, at least in part by influencing tumor neovascularization.
  • References
    • Deroanne C, et al. (2003) EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway. J Cell Sci. 116(7): 1367-76.
    • Ojima T, et al. (2006) EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown. Am J Pathol. 168(1): 331-9.
    • Wu D, et al. (2004) Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol. 94(2): 312-9.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"